MICROMET
Micromet is a biotechnology company focused on the research, development and commercialization of novel biological products for the treatment and control of cancer. Their lead product candidate, Canvaxin, is one of a new class of products being developed in the area of specific active immunotherapy, also known as therapeutic cancer vaccines.
MICROMET
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
1993-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.cancervax.com
Status:
Closed
Contact:
+490898952770
Total Funding:
146.5 M USD
Current Advisors List
Stock Details
Investors List
Index Ventures
Index Ventures investment in Post-IPO Equity - Micromet
Merlin Nexus
Merlin Nexus investment in Post-IPO Equity - Micromet
NGN Capital
NGN Capital investment in Post-IPO Equity - Micromet
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - Micromet
Abingworth
Abingworth investment in Post-IPO Equity - Micromet
Vector Fund Management
Vector Fund Management investment in Series C - Micromet
JPMorgan Partners
JPMorgan Partners investment in Series C - Micromet
Amerindo Investment Advisors
Amerindo Investment Advisors investment in Series C - Micromet
Forward Ventures
Forward Ventures investment in Series C - Micromet
SV Health Investors
SV Health Investors investment in Venture Round - Micromet
Official Site Inspections
http://www.cancervax.com Semrush global rank: 5.35 M Semrush visits lastest month: 1.56 K
- Host name: 104.26.8.85
- IP address: 104.26.8.85
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
